Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Tonabersat by Inflammx Therapeutics for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Tonabersat is under clinical development by Inflammx Therapeutics and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration....
Tonabersat by Inflammx Therapeutics for Dry (Atrophic) Macular Degeneration: Likelihood of Approval
Tonabersat is under clinical development by Inflammx Therapeutics and currently in Phase II for Dry (Atrophic) Macular Degeneration. According to...
Tonabersat by Inflammx Therapeutics for Diabetic Nephropathy: Likelihood of Approval
Tonabersat is under clinical development by Inflammx Therapeutics and currently in Phase II for Diabetic Nephropathy. According to GlobalData, Phase...
Tonabersat by Inflammx Therapeutics for Diabetic Macular Edema: Likelihood of Approval
Tonabersat is under clinical development by Inflammx Therapeutics and currently in Phase II for Diabetic Macular Edema. According to GlobalData,...